Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chinese Premier, In Rare Online Chat, Pledges Higher Levels Of State Reimbursement For Medical Care And Insurance

This article was originally published in PharmAsia News

Executive Summary

BEIJING - In an almost-live online chat this week with China's cyber-citizenry, Premier Wen Jiabao vowed to strengthen China's social safety net, including upgraded medical services and insurance, while stating "every citizen should share the fruits of the reform and opening up drive.

You may also be interested in...



Cost Of China Healthcare Reforms Exceeds RMB 1 Trillion; Government Raises Reimbursement Ceilings

BEIJING - As leaders in China's central government gathered last week in Beijing to take part in the National People's Congress, they revealed that the price of ever-expanding healthcare reforms, ultimately aimed at providing universal coverage and commonly affordable medical care through measures including the national Essential Drug List, has already risen above RMB 1 trillion

Cost Of China Healthcare Reforms Exceeds RMB 1 Trillion; Government Raises Reimbursement Ceilings

BEIJING - As leaders in China's central government gathered last week in Beijing to take part in the National People's Congress, they revealed that the price of ever-expanding healthcare reforms, ultimately aimed at providing universal coverage and commonly affordable medical care through measures including the national Essential Drug List, has already risen above RMB 1 trillion

Sihuan And Other Leading Chinese Drug Firms Could Get Boost From Current Meeting Of National People's Congress In Beijing

BEIJING - Sihuan Pharmaceutical Holdings Group, based on the tropical Chinese island of Hainan, could see a sharp upward trajectory in earnings over the next three years as it continues to expand its product portfolio through acquisitions fueled by proceeds raised during its initial public offering and a government push to consolidate the Chinese pharmaceutical industry

Related Content

Latest News
See All
UsernamePublicRestriction

Register

SC077522

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel